Tolppanen Anna-Maria, Lamminmäki Annamarja, Kataja Vesa, Tyynelä-Korhonen Kristiina
Center of Oncology, The Wellbeing Services County of North Savo, Kuopio, Finland.
University of Eastern Finland, Kuopio, Finland.
BMC Palliat Care. 2024 Dec 28;23(1):302. doi: 10.1186/s12904-024-01633-x.
Studies show that hospital deaths bring significant health care costs, and the involvement of specialized palliative care can help to reduce these costs. The aim of this retrospective registry-based study was to evaluate end-of-life hospital costs in patients dying in a university hospital oncology ward, with or without specialized palliative outpatient clinic contact at any timepoint.
The study population consists of all patients who died in the Kuopio University Hospital oncology ward in the years 2012-2018 (n = 457). Hospital costs in the last 30 days of life and data on treatment decisions and background factors were gathered. Costs for patients with and without palliative care contact were compared. Effects of various variables on the costs were analyzed using gamma regression model.
Both the last 14 days' and 30 days' hospital costs before death were significantly lower among those 65 patients [14.2%] who had had a specialist palliative care contact. This was seen in inpatient day costs, microbiology, radiation therapy, laboratory, drug, radiology, and total costs. In a multivariate analysis including age, gender, year of death, time from diagnosis to death, and cancer type, the costs for 30 days prior to death were 33% lower in those patients who had had palliative care contact.
Our results provide first indications that a contact to specialist palliative care in an outpatient clinic may reduce end-of-life hospital care costs in hospital-deceased cancer patients.
研究表明,医院死亡会带来巨大的医疗保健成本,而专业姑息治疗的介入有助于降低这些成本。这项基于回顾性登记的研究旨在评估在大学医院肿瘤科病房死亡的患者的临终医院成本,无论其在任何时间点是否与专业姑息门诊有过接触。
研究人群包括2012年至2018年在库奥皮奥大学医院肿瘤科病房死亡的所有患者(n = 457)。收集了生命最后30天的医院成本以及治疗决策和背景因素的数据。比较了有和没有姑息治疗接触的患者的成本。使用伽马回归模型分析了各种变量对成本的影响。
在有专业姑息治疗接触的65名患者[14.2%]中,死亡前最后14天和30天的医院成本均显著降低。这在住院日成本、微生物学、放射治疗、实验室、药物、放射学和总成本方面都有体现。在包括年龄、性别、死亡年份、从诊断到死亡的时间以及癌症类型的多变量分析中,有姑息治疗接触的患者死亡前30天的成本降低了33%。
我们的结果首次表明,在门诊与专业姑息治疗接触可能会降低在医院去世的癌症患者的临终医院护理成本。